MP-EV20-89Zr

N/A

Report date: 2025/09/10 10:58:27

Base Information

Drug NameMP-EV20-89Zr

Drug Alias NameMP-EV20 radiolabelled with zirconium-89 (MediaPharma)MP-89Zr-EV20MP-EV20-RT

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonists

TargetsReceptor tyrosine-protein kinase erbB-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedia Pharma SRL

China Registration ClassN/A

Develop Information

Active CompaniesMedia Pharma SRL

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A